Spire Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Spire Wealth Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25	Closed	-$984	–	2505
2023 Q2	$984	Hold	25	–	–	﹤0.01%	2311
2023 Q1	$608	Buy	+25	New	+$547	﹤0.01%	2457
2022 Q3	–	Sell	-800	Closed	-$8K	–	2704
2022 Q2	$8K	Sell	800 -800	-50%	-$10K	﹤0.01%	2008
2022 Q1	$27K	Sell	1,600 -25	-2%	-$369	﹤0.01%	1692
2021 Q4	$27K	Buy	1,625 +25	+2%	+$410	﹤0.01%	2016
2021 Q3	$26K	Sell	1,600 -1,600	-50%	-$17.4K	﹤0.01%	1755
2021 Q2	$20K	Sell	3,200 -25	-0.8%	-$161	﹤0.01%	1877
2021 Q1	$20K	Buy	+3,225	New	+$19.6K	﹤0.01%	2159

Spire Wealth Management's ISEE Position: Q3 2023 in Review

Spire Wealth Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 25 shares — an estimated $984 sold.

Spire Wealth Management first reported a position in ISEE in Q1 2021 and held it in 8 quarters. The position peaked at $27K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Spire Wealth Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Spire Wealth Management sold 25 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $984.
Spire Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Spire Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $27K in Q1 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.